The Role of N-Acetyl Transferases on Isoniazid Resistance from Mycobacterium tuberculosis and Human: An In Silico Approach
Ameeruddin Nusrath Unissa, Swathi Sukumar, Luke Elizabeth Hanna
Tuberc Respir Dis. 2017;80(3):255-264.   Published online 2017 Jul 3     DOI: https://doi.org/10.4046/trd.2017.80.3.255
Citations to this article as recorded by Crossref logo
Extrapulmonary tuberculosis in Africa: Molecular analysis of clinical specimens of suspected cases in Northern Ghana
Yaa Nyarko Addai, Samuel E. K. Acquah, Honesty Mensah Ganu, Ezekiel Kofi Vicar, David Zeyeh, Abass Abdul Karim, Walana Williams, Israel Mensah Attipoe, Lawrence Quaye
Public Health Challenges.2024;[Epub]     CrossRef
NAT2 polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicity
Nur Farhana Mohamed Noor, Mohd Zaki Salleh, Mohd Arif Mohd Zim, Zamzurina Abu Bakar, Mohd Nur Fakhruzzaman Noorizhab, Noor Izyani Zakaria, Muhammad Imran Lailanor, Lay Kek Teh
Pharmacogenomics.2022; 23(9): 531.     CrossRef
Genetic characterization of N-acetyltransferase 2 variants in acquired multidrug-resistant tuberculosis in Indonesia
Rika Yuliwulandari, Kinasih Prayuni, Intan Razari, Retno W Susilowati, Yenni Zulhamidah, Soedarsono Soedarsono, Abdul Salam M Sofro, Katsushi Tokunaga
Pharmacogenomics.2021; 22(3): 157.     CrossRef
Development of a limited sampling strategy for the estimation of isoniazid exposure considering N-acetyltransferase 2 genotypes in Korean patients with tuberculosis
Jihyun Lee, Giwon Choi, Seungwon Yang, Jung-Eun Ha, Eun Sun Kim, Jong Sun Park, Kyunghoon Lee, Junghan Song, Jae Ho Lee, Jangik I. Lee
Tuberculosis.2021; 127: 102052.     CrossRef
Acetylator Status Among Newly Diagnosed and Recurrent Tuberculosis Patients from Kupang, Eastern Part of Indonesia
Edhyana Sahiratmadja, Ika Agus Rini, Simeon Penggoam, Afandi Charles, Ani Melani Maskoen, Ida Parwati
Pharmacogenomics and Personalized Medicine.2021; Volume 14: 737.     CrossRef
Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity
Fernando Carrasco, Wilfredo Hernández, Oscar Chupayo, Patricia Sheen, Mirko Zimic, Jorge Coronel, Celedonio M. Álvarez, Sergio Ferrero, Sandra Oramas-Royo, Evgenia Spodine, Jesus M. Rodilla, Juan Z. Dávalos, Marcelino Maneiro
Journal of Chemistry.2021; 2021: 1.     CrossRef
Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs
K Prso, N Zidekova, M Dohal, I Porvaznik, M Prso, M Kertys, J Mokry
Acta Medica Martiniana.2020; 20(2): 45.     CrossRef